Generic Drug Prices Should Be 50% Of Originator: Japan’s MHLW
This article was originally published in PharmAsia News
Executive Summary
Japan’s MHLW has submitted a proposal to the Central Social Insurance Medical Council’s Committee on Drug Price suggesting that the price of generic drugs to be added to the NHI price listing should be 50% of the price of originator drugs.